Exagen Diagnostics Inc.

Scott Glenn Joins Exagen Diagnostics as Chairman and CEO.
Blood Weekly; 12/17/2009; 896 words; Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops...s board of directors and chief executive officer (see also Exagen Diagnostics, Inc.). Prior to joining Exagen, Glenn was managing partner of...

Other News To Note.
BIOWORLD Today; 12/2/2009; 1549 words; ...detection of influenza A and B. o Exagen Diagnostics Inc., of Albuquerque, N.M...board and CEO. Prior to joining Exagen, Glenn was managing partner of...Germany, and Complete Genomics Inc., of Mountain View, Calif...

Research and Markets Offers Report: Molecular Diagnostics Survey 2009
Wireless News; 11/19/2009; 813 words; ...Report: Molecular Diagnostics Survey 2009Type...the "Molecular Diagnostics Survey 2009: A...covers molecular diagnostic testing performed...pharmacogenetic and companion diagnostic tests for use in...EraGen Biosciences - eXagen Diagnostics - Gen-Probe...Close-Up Media, Inc. ...

Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1202 words; ...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., appointed...George Horner to its board. EntreMed Inc., of Rockville, Md., appointed...its scientific advisory board. Exagen Diagnostics Inc., of Albuquerque, N.M., appointed...

Patent No. 7,561,971 Issued on July 14, Assigned to Exagen Diagnostics for Classifier Performance Estimating Method (New Mexico Inventor)
US Fed News Service, Including US State News; 7/18/2009; 413 words; ...performance. The inventor was issued U.S. Patent No. 7,561,971 on July 14. The patent has been assigned to Exagen Diagnostics Inc., Albuquerque. According to the abstract released by the U.S. Patent & Trademark Office: "Methods...